Advertisement
Canada markets closed
  • S&P/TSX

    22,011.72
    +139.76 (+0.64%)
     
  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     
  • DOW

    38,503.69
    +263.71 (+0.69%)
     
  • CAD/USD

    0.7323
    +0.0002 (+0.03%)
     
  • CRUDE OIL

    83.43
    +0.07 (+0.08%)
     
  • Bitcoin CAD

    91,186.42
    -181.01 (-0.20%)
     
  • CMC Crypto 200

    1,431.08
    +16.32 (+1.15%)
     
  • GOLD FUTURES

    2,334.90
    -7.20 (-0.31%)
     
  • RUSSELL 2000

    2,002.64
    +35.17 (+1.79%)
     
  • 10-Yr Bond

    4.5980
    -0.0520 (-1.12%)
     
  • NASDAQ futures

    17,715.25
    +108.50 (+0.62%)
     
  • VOLATILITY

    15.69
    -1.25 (-7.38%)
     
  • FTSE

    8,044.81
    +20.94 (+0.26%)
     
  • NIKKEI 225

    38,315.27
    +763.11 (+2.03%)
     
  • CAD/EUR

    0.6834
    -0.0002 (-0.03%)
     

How Canopy Growth Is Preparing for Legalized Cannabis

How Canopy Growth Is Preparing for Legalized Cannabis

During 3Q18, Canopy Growth increased its inventory and biological assets to a value of 108.3 Canadian dollars from 56 million Canadian dollars in 3Q17. The company stated that it continues to scale inventory to meet the rising demand that will likely result when cannabis is legalized in Canada later in 2018. With investment activities in the cannabis sector ramping up, Canopy Growth and other players (HMLSF) such as Cronos (PRMCF), MedReleaf (MEDFF), Aphria (APHQF), and Aurora Cannabis (ACBFF) will continue to make investments.